ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660313; 2) Community: the network communities that were significantly associated with the response to NSC 660313; 3) Molecule: the relationships between components within communities and NSC 660313; 4) MDR: the compounds that were significantly associated with the NSC 660313.

NSC Compound Enrichment Correlation
NSC 673787 Null 0.0297837393005856 0.25918508
NSC 678869 Benz[a]anthracene-6,6-dicarboxylic acid, 5,6,7,12- tetrahydro-2-methoxy-7,12-dioxo-, dimethyl ester 0.0297837393005856 0.26761254
NSC 681641 Camptothecin Derivative 0.0297837393005856 0.21148399
NSC 684118 Pyrido[3,4-g]quinoline-5,10-dione, 1,4-dihydro- 1-(dimethylamino)-4-methyl- 0.0297837393005856 -0.0021214605
NSC 693135 Null 0.0297837393005856 0.18743756
NSC 697730 Null 0.0297837393005856 -0.11268261
NSC 716715 Null 0.0297837393005856 0.38464055
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0297837393005856 0.2584131
NSC 736818 Null 0.0297837393005856 0.3377651
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0297837393005856 0.20355464
Total:58  Current:35    [First] [Prev] [Next] [Last]